leflunomide has been researched along with Drug Hypersensitivity in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vesel, T | 1 |
Luzar, B | 1 |
Calonje, E | 1 |
Avcin, T | 1 |
Suzuki, Y | 1 |
Saito, E | 1 |
Wakabayashi, T | 1 |
Suwa, A | 1 |
1 review available for leflunomide and Drug Hypersensitivity
Article | Year |
---|---|
[Adverse effects of conventional DMARDs and biologic DMARDs].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug | 2007 |
1 other study available for leflunomide and Drug Hypersensitivity
Article | Year |
---|---|
Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Hypersensit | 2009 |